Compare STLA & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STLA | VEEV |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7B | 36.9B |
| IPO Year | N/A | 2013 |
| Metric | STLA | VEEV |
|---|---|---|
| Price | $9.73 | $222.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 26 |
| Target Price | $12.49 | ★ $303.52 |
| AVG Volume (30 Days) | ★ 12.5M | 1.5M |
| Earning Date | 02-25-2026 | 03-04-2026 |
| Dividend Yield | ★ 5.93% | N/A |
| EPS Growth | N/A | ★ 26.69 |
| EPS | N/A | ★ 5.13 |
| Revenue | ★ $171,605,402,237.00 | $3,080,246,000.00 |
| Revenue This Year | $0.20 | $17.74 |
| Revenue Next Year | $5.45 | $12.28 |
| P/E Ratio | ★ N/A | $43.27 |
| Revenue Growth | N/A | ★ 15.96 |
| 52 Week Low | $8.39 | $201.54 |
| 52 Week High | $14.28 | $310.50 |
| Indicator | STLA | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 36.99 | 43.71 |
| Support Level | $9.32 | $215.55 |
| Resistance Level | $11.32 | $226.64 |
| Average True Range (ATR) | 0.26 | 7.12 |
| MACD | -0.11 | 0.28 |
| Stochastic Oscillator | 19.95 | 23.20 |
Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2024 it sold 5.5 million vehicles, 47%, 26% and 17% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.